Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're on Mounjaro and wondering whether sunbed sessions are safe to continue, you're asking the right question. Tirzepatide does not directly interact with UV light in a pharmacological sense, but there are practical skin and safety considerations worth understanding before you book your next session. Mounjaro is a prescription-only medicine requiring clinical assessment, so any questions specific to your situation are best put to your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's a scenario a question our prescribers hear most weeks: someone is a few weeks into Mounjaro, feeling good, and wants to know whether their usual sunbed routine needs to change. The short answer is that there is no documented pharmacological interaction between tirzepatide and ultraviolet light. Mounjaro does not make your skin absorb UV differently, and it is not listed among medicines that cause photosensitivity in the clinical literature.
That said, 'no direct interaction' is not quite the same as 'carry on as normal.' The side effects most people experience early in treatment (nausea, vomiting, diarrhoea) can leave you more dehydrated than usual. Sunbeds add a dehydration load on top of that. Heat from a sunbed also causes peripheral blood vessels to dilate, which, when combined with the dizziness some patients report on tirzepatide, could make you feel faint or unsteady when you stand up afterwards. Practical advice: make sure you are well hydrated before any heat or UV session, especially in the early weeks of treatment or after a dose increase.
The NHS tirzepatide patient information page lists dizziness and nausea among the more common side effects, worth reading in full if you haven't already, as it sets out clearly what to expect and when to seek help. If you are taking any additional medicines alongside Mounjaro, your prescriber should review those too, since some drugs do cause photosensitivity independently. You can read more about tirzepatide and how it works over on our tirzepatide information page.
Injection-site reactions are listed in the Mounjaro SmPC as a known side effect. These present as redness, swelling or mild irritation at the injection point, abdomen, thigh or upper arm. Exposing a recently injected site to sunbed UV is worth avoiding simply because any existing skin irritation can be aggravated by heat and UV radiation. Rotate away from recently injected areas when choosing which part of your body goes directly under the lamp.
More broadly, if you notice any unusual skin changes (unexpected redness, rash, or sensitivity that coincides with starting or increasing your dose) it is worth documenting them and mentioning them to your prescriber. Mounjaro carries a Black Triangle (▼) designation from the MHRA, which means post-marketing safety data is still actively being collected. Suspected side effects, including any unexpected skin reactions, can be reported directly to the MHRA at yellowcard.mhra.gov.uk, that reporting genuinely helps build the evidence base for everyone on the medicine.
If you are also interested in how Mounjaro relates to sun exposure more generally, the page on Mounjaro and sun exposure covers outdoor UV, SPF, and heat in more detail. For anything touching your skin specifically, our Mounjaro and sunburn page addresses what to do if you burn while on treatment.
Sometimes 'can I use sunbeds on Mounjaro' is really a question about wellbeing more broadly, about whether everyday habits need to change when you start a new treatment. The honest answer is: mostly no, but with awareness. Mounjaro is not a medicine that puts your whole lifestyle on hold. It works best alongside the things that support it, staying hydrated, eating adequate protein, being active within what feels manageable. Sunbeds don't sit outside that picture, provided you are not already struggling with dehydration or dizziness.
If you have any additional health conditions (connective tissue concerns, skin conditions that respond to UV, or anything else that changes how your body handles heat) the calculus shifts. Our clinical team at nume's clinical oversight page gives a sense of the standard of review involved. Every repeat order at Mounjaro treatment through nume is clinically re-reviewed, so if your circumstances change, your prescriber hears about it. That continuity matters more than any single session decision.
If you are thinking about starting Mounjaro or have questions about whether it is right for your situation, taking a look at what the consultation covers is a sensible starting point. Our FAQs also cover a range of practical lifestyle questions that come up during treatment, including our page on Mounjaro and clogged ears for those who have noticed changes to their hearing during treatment. Speak to our prescribers if anything about your skin, hydration or how you feel under treatment is giving you pause, and if you are based in Yorkshire, our Mounjaro service in Leeds can connect you with local prescribing support.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.